Allgens Medical Technology CO., LTD.
Shanghai Stock Exchange 688613.SS
Allgens Medical Technology CO., LTD. Price to Sales Ratio (P/S) on January 14, 2025: 9.97
Allgens Medical Technology CO., LTD. Price to Sales Ratio (P/S) is 9.97 on January 14, 2025, a -18.98% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.
-
Allgens Medical Technology CO., LTD. 52-week high Price to Sales Ratio (P/S) is 12.33 on January 16, 2024, which is 23.68% above the current Price to Sales Ratio (P/S).
-
Allgens Medical Technology CO., LTD. 52-week low Price to Sales Ratio (P/S) is 6.79 on June 06, 2024, which is -31.83% below the current Price to Sales Ratio (P/S).
-
Allgens Medical Technology CO., LTD. average Price to Sales Ratio (P/S) for the last 52 weeks is 8.90.
Key data
| Date | Price to Sales Ratio (P/S) | Price to Book Ratio (P/B) | Dividend Yield | Free Cash Flow Yield |
|---|
Market news
Loading...
Shanghai Stock Exchange: 688613.SS
| CEO | Mr. Menglong Cui |
| IPO Date | May 21, 2021 |
| Location | China |
| Headquarters | Building 2 |
| Employees | 202 |
| Sector | Health Care |
| Industries | |
Description
Allgens Medical Technology CO., LTD., a medical device company, develops and manufactures platforms of biomimetic synthetic bone grafts for use in regions of compromised cancellous and cortical bone worldwide. The company offers BonGold mineralized collagen scaffold bone graft; Alligator high performance bone marrow aspirator; and OssaNova mineralized collagen-based bone filling augmentation material. Its products are used in various skeletal applications in and around the human skeleton. Allgens Medical Technology CO., LTD. was founded in 2004 and is based in Beijing, China.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email